Data Foundry

Drug recalls 2017

Glycopyrrolate Injection Solution — Class II drug recall D-1065-2017

Terminated recall by Cantrell Drug Company, reported 2017-08-16, distributed nationwide. Lack of Sterility Assurance.

Recall numberD-1065-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCantrell Drug Company, Little Rock, AR, United States
Recall initiated2017-07-14
Classified2017-08-09
Reported by FDA2017-08-16
Terminated2020-09-16
DistributedNationwide (US)
Quantity75,840 syringes
Reason classessterility
NDC52533-0028-15
Lot numbers10022, 10052, 10063, 10086, 10108, 10156, 10180, 10245, 10264, 10322, 10339, 10368, 10406, 10419, 10435, 10455, 10489, 10497, 10516, 10527, 10577, 9783, 9801, 9807, 9847, 9954
Expiration dates2017-07-27, 2017-07-29, 2017-07-30, 2017-08-04, 2017-08-20, 2017-09-01, 2017-09-06, 2017-09-07, 2017-09-09, 2017-09-13, 2017-09-20, 2017-09-22, 2017-09-29, 2017-09-30, 2017-10-08, 2017-10-13, 2017-10-18, 2017-10-25, 2017-10-26, 2017-10-28, 2017-11-01, 2017-11-05, 2017-11-06, 2017-11-09, 2017-11-10 and 1 more

Product

Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-15

Reason for recall

Lack of Sterility Assurance.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1065-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.